Nikolaus D. Schultz
Impact in
- Cancer Research top 0.01%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 0.01%
- Cancer Immunotherapy and Biomarkers
Papers in
- Cancer Research 152
- Cancer Genomics and Diagnostics 122
- Oncology 80
- Co-authors
- Chris Sander (39 shared papers)Bülent Arman Aksoy (9 shared papers)Ethan G Cerami (7 shared papers)Jianjiong Gao (18 shared papers)Selçuk Onur Sümer (6 shared papers)Erik Larsson (4 shared papers)Uğur Doğrusöz (4 shared papers)Benjamin E Gross (2 shared papers)
- Journals
- Clinical Cancer Research (33 papers)Cancer Cell (22 papers)Nature Communications (22 papers)Cell (21 papers)Cancer Discovery (20 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Nikolaus D. Schultz
371 papers receiving 138.5k citations
Nikolaus D. Schultz's Hit Papers
Peers
Comparison fields: 5 of 205
- Cancer Research 40.2k
- Oncology 35.8k
- Pulmonary and Respiratory Medicine 31.7k
- Molecular Biology 64.9k
- Genetics 8.0k
Countries citing papers authored by Nikolaus D. Schultz
This map shows the geographic impact of Nikolaus D. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolaus D. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolaus D. Schultz more than expected).
Fields of papers citing papers by Nikolaus D. Schultz
This network shows the impact of papers produced by Nikolaus D. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolaus D. Schultz. The network helps show where Nikolaus D. Schultz may publish in the future.
Co-authors
The 25 scholars most cited alongside Nikolaus D. Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 384 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data Hit paper breakdown → | 2012 | 13432 |
| 2 | Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal Hit paper breakdown → | 2013 | 11954 |
| 3 | Comprehensive genomic characterization defines human glioblastoma genes and core pathways Hit paper breakdown → | 2008 | 6384 |
| 4 | Integrated genomic analyses of ovarian carcinoma Hit paper breakdown → | 2011 | 6345 |
| 5 | Comprehensive molecular characterization of gastric adenocarcinoma Hit paper breakdown → | 2014 | 5209 |
| 6 | The Somatic Genomic Landscape of Glioblastoma Hit paper breakdown → | 2013 | 3977 |
| 7 | Integrative Genomic Profiling of Human Prostate Cancer Hit paper breakdown → | 2010 | 3078 |
| 8 | Integrative Clinical Genomics of Advanced Prostate Cancer Hit paper breakdown → | 2015 | 2985 |
| 9 | Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients Hit paper breakdown → | 2017 | 2650 |
| 10 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2602 |
| 11 | Genomic Classification of Cutaneous Melanoma Hit paper breakdown → | 2015 | 2509 |
| 12 | Integrated Genomic Characterization of Papillary Thyroid Carcinoma Hit paper breakdown → | 2014 | 2442 |
| 13 | The Molecular Taxonomy of Primary Prostate Cancer Hit paper breakdown → | 2015 | 2435 |
| 14 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 15 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2334 |
| 16 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2109 |
| 17 | OncoKB: A Precision Oncology Knowledge Base Hit paper breakdown → | 2017 | 1972 |
| 18 | Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma Hit paper breakdown → | 2017 | 1970 |
| 19 | Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer Hit paper breakdown → | 2017 | 1931 |
| 20 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1720 |
About Nikolaus D. Schultz
Nikolaus D. Schultz is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology, having authored 384 papers that have together received 140.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (122 papers), Genetic factors in colorectal cancer (44 papers), Prostate Cancer Treatment and Research (28 papers), Bioinformatics and Genomic Networks (25 papers), RNA modifications and cancer (21 papers), Epigenetics and DNA Methylation (21 papers), Lung Cancer Treatments and Mutations (20 papers) and Genomics and Rare Diseases (17 papers). The work is most often cited by research in Cancer Research (40.2k citations), Oncology (35.8k citations), Pulmonary and Respiratory Medicine (31.7k citations), Molecular Biology (64.9k citations) and Genetics (8.0k citations). Nikolaus D. Schultz has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Chris Sander, Bülent Arman Aksoy, Ethan G Cerami, Jianjiong Gao, Selçuk Onur Sümer, Erik Larsson, Uğur Doğrusöz, Benjamin E Gross, Rileen Sinha and Boris A. Reva. Their work appears in journals such as Clinical Cancer Research, Cancer Cell, Nature Communications, Cell and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.